Cold Spring Harbor Laboratory: Calibrating Kidney Function for Cancer Patients
December 11, 2020
December 11, 2020
COLD SPRING HARBOR, New York, Dec. 11 -- The Cold Spring Harbor Laboratory issued the following news:
Cold Spring Harbor Laboratory (CSHL) scientists have developed a new model for assessing kidney function in cancer patients as part of an international collaboration that involved contributions from the United Kingdom and Sweden. The model gives clinicians a new tool to aid dose determinations for chemotherapy to treat a patient's disease while limiting the drugs' harmful effects.
Cold Spring Harbor Laboratory (CSHL) scientists have developed a new model for assessing kidney function in cancer patients as part of an international collaboration that involved contributions from the United Kingdom and Sweden. The model gives clinicians a new tool to aid dose determinations for chemotherapy to treat a patient's disease while limiting the drugs' harmful effects.